These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 30747085)

  • 21. Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study.
    Godsland IF; Elkeles RS; Feher MD; Nugara F; Rubens MB; Richmond W; Khan M; Donovan J; Anyaoku V; Flather MD;
    Diabet Med; 2006 Nov; 23(11):1192-200. PubMed ID: 17054594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein.
    Rhee EJ; Lee WY; Kim SY; Kim BJ; Sung KC; Kim BS; Kang JH; Oh KW; Oh ES; Baek KH; Kang MI; Woo HY; Park HS; Kim SW; Lee MH; Park JR
    Clin Sci (Lond); 2005 Mar; 108(3):237-43. PubMed ID: 15569000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus.
    Guzel S; Seven A; Kocaoglu A; Ilk B; Guzel EC; Saracoglu GV; Celebi A
    Diab Vasc Dis Res; 2013 Jan; 10(1):25-31. PubMed ID: 22496403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.
    Asanuma Y; Chung CP; Oeser A; Solus JF; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
    Atherosclerosis; 2007 Dec; 195(2):e135-41. PubMed ID: 17570371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.
    Morisawa T; Nakagomi A; Kohashi K; Kusama Y; Shimizu W
    J Atheroscler Thromb; 2017 Oct; 24(10):1058-1068. PubMed ID: 28428481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects.
    Stępień E; Fedak D; Klimeczek P; Wilkosz T; Banyś RP; Starzyk K; Bazanek M; Pasowicz M
    Hypertens Res; 2012 May; 35(5):531-8. PubMed ID: 22278625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
    Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
    Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoprotegerin as a marker of atherosclerosis in type 1 and type 2 diabetic patients.
    Alkaç C; Alkaç B; Akbaş F; Aral H; Karagöz Y; Altunoğlu EG
    Turk J Med Sci; 2015; 45(6):1306-11. PubMed ID: 26775387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men.
    Ketlogetswe KS; McKibben R; Jacobson LP; Li X; Dobs AS; Budoff M; Witt MD; Palella FJ; Kingsley L; Margolick JB; Post WS; Brown TT
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):362-9. PubMed ID: 26090754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between osteoprotegerin and coronary artery calcification in diabetic subjects: a systematic review of observational studies.
    Vazirian F; Sadeghi M; Wang D; Javidi Dashtbayaz R; Gholoobi A; Samadi S; Mohammadpour AH
    BMC Cardiovasc Disord; 2023 Feb; 23(1):96. PubMed ID: 36809976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males?
    Rozas Moreno P; Reyes García R; García-Martín A; Varsavsky M; García-Salcedo JA; Muñoz-Torres M
    J Endocrinol Invest; 2013 Jan; 36(1):16-20. PubMed ID: 22391059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria.
    Reinhard H; Nybo M; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rasmussen LM; Rossing P; Jacobsen PK
    Cardiovasc Diabetol; 2011 Jul; 10():70. PubMed ID: 21801376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden/structure in patients with type 2 diabetes mellitus.
    Ozturk D; Celik O; Satilmis S; Aslan S; Erturk M; Cakmak HA; Kalkan AK; Ozyilmaz S; Diker V; Gul M
    Coron Artery Dis; 2015 Aug; 26(5):396-401. PubMed ID: 25887000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between circulating serum osteoprotegerin and total receptor activator of nuclear κ-B ligand levels, triglycerides, and coronary calcification in postmenopausal women.
    Poornima IG; Mackey RH; Buhari AM; Cauley JA; Matthews KA; Kuller LH
    Menopause; 2014 Jul; 21(7):702-10. PubMed ID: 24473535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease.
    Adamczyk T; Mizia-Stec K; Mizia M; Haberka M; Chmiel A; Chudek J; Gąsior Z
    Pol Arch Med Wewn; 2012; 122(1-2):14-21. PubMed ID: 22237719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence.
    Hangai M; Takebe N; Honma H; Sasaki A; Chida A; Nakano R; Togashi H; Nakagawa R; Oda T; Matsui M; Yashiro S; Nagasawa K; Kajiwara T; Takahashi K; Takahashi Y; Satoh J; Ishigaki Y
    J Atheroscler Thromb; 2016 Oct; 23(10):1178-1187. PubMed ID: 26961217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality.
    Lieb W; Gona P; Larson MG; Massaro JM; Lipinska I; Keaney JF; Rong J; Corey D; Hoffmann U; Fox CS; Vasan RS; Benjamin EJ; O'Donnell CJ; Kathiresan S
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1849-54. PubMed ID: 20448212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of sarpogrelate, a selective 5-HT
    Lee DH; Chun EJ; Hur JH; Min SH; Lee JE; Oh TJ; Kim KM; Jang HC; Han SJ; Kang DK; Kim HJ; Lim S
    Atherosclerosis; 2017 Feb; 257():47-54. PubMed ID: 28068560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic type 2 diabetic patients.
    Tsuchiya M; Suzuki E; Egawa K; Nishio Y; Maegawa H; Inoue S; Mitsunami K; Morikawa S; Inubushi T; Kashiwagi A
    Diabetes Care; 2004 Oct; 27(10):2409-15. PubMed ID: 15451909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.